Evaluation of the E/e' Ratio of the Mitral Annulus in Predicting Fluid Responsiveness.
NCT ID: NCT02714244
Last Updated: 2017-09-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
70 participants
INTERVENTIONAL
2016-01-31
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this study is to evaluate the predictive value of the mitral valve E/e' ratio for fluid responsiveness among patients undergoing coronary bypass graft surgery. Fluid responsiveness being defined as an increase in stroke volume of ≥ 15%.
After induction of anesthesia, patients will have their diastolic function evaluated by means of E/e' and other measures. They will then be administered an intravenous bolus of 500 mL of Lactate Ringer® along with passive leg raising (PLR). Stroke volume and fluid responsiveness will be assessed by the thermodilution method (Swan-Ganz catheter) and the FloTrac® device. Fluid responders will be compared to non-responders to evaluate the relationship between E/e' ratio and fluid responsiveness.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Left Atrial Distensibility to Predict Prognosis in Consecutive Patients
NCT01171040
Trans-thoracic Ultrasound VS Invasive Pressure of the Left Atrium
NCT03012308
Evaluation of Left Ventricular Volumes by Real-Time 3-Dimensional Echocardiography
NCT00001740
Evaluation of Radial Strain for Assessment of Left Ventricular Function in Transesophageal Echocardiography
NCT01080495
Intraoperative Diastolic Function by TDI and STE
NCT03088943
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Volume expansion
Volume expansion with rapid administration of 500 ml of crystalloid
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Significant right sided valvular heart disease (tricuspid regurgitation ≥ 2/4)
* Intracardiac shunts
* Emergency surgery
* Non-sinusal rythme
* Clinical evidence of decompensated heart failure
* Clinical evidence of decompensated pulmonary hypertension
* Renal insufficiency with creatinine clairance ≤ 30 cc/min or dialysis
* Contraindications to TEE, including esophageal disease or unstable cervical spine
* CVP ≥ 15 mm Hg or PCWP ≥ 18 mm Hg immediately before fluid infusion
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Montreal Heart Institute
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Montreal Heart Institute
Montreal, Quebec, Canada
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Courbe A, Perrault-Hebert C, Ion I, Desjardins G, Fortier A, Denault A, Deschamps A, Couture P. Should we use diastolic function parameters to determine preload responsiveness in cardiac surgery? A pilot study. J Anesth Analg Crit Care. 2021 Oct 30;1(1):12. doi: 10.1186/s44158-021-00014-7.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2014-1671
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.